Company intelligence / Profile preview

Wuhan Ruidifu Biotechnology

Wuhan, Hubei, Chinaruidifu.com ↗
Ownership
Private
Employees
~100
Development stage
Other
01

Overview

Wuhan Ruidifu Biotechnology is a specialized life sciences company headquartered in Wuhan, China, focusing on the research and production of core raw materials for the in vitro diagnostics (IVD) industry. The company provides an extensive catalog of high-purity recombinant antigens and monoclonal antibodies tailored for use in various immunoassay platforms, including chemiluminescence, ELISA, and rapid diagnostic tests. Their product portfolio covers critical diagnostic areas such as infectious diseases, cardiac markers, inflammation, and tumor markers. Ruidifu utilizes advanced protein expression platforms across bacterial, yeast, and mammalian cell systems to ensure high bioactivity and consistency in their reagents. In addition to off-the-shelf products, the company offers customized antibody development and protein expression services to meet specific client requirements in the global diagnostic industry.

Therapeutic areas
OncologyCardiovascularImmunologyInfectious Diseases
Modalities
Monoclonal antibodyRecombinant proteinAntigen
Industry
Chemicals & Materials

Beyond the preview

Go deeper on Wuhan Ruidifu Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Ruidifu Biotechnology.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call